Cancer Detection

IMI reports development progress on three cancer-detection tests

Published in Cancer Weekly, December 24th, 2002

Predictive medicine company IMI International Medical Innovations, Inc., (TSX:IMI) reported progress on its development and clinical testing of the company's three lead cancer- detection tests that are based on the same marker and core technology: ColorectAlert for colorectal cancer, LungAlert for lung cancer and a new test for breast cancer.

Upon completion of the analysis of studies involving each of the three cancer tests the company will publicly release the detailed data to coincide with publication or presentation of the findings to the medical community.

ColorectAlert is a minimally invasive screening test for colorectal cancer that identifies...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-12-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry